This expands Nova Biomedical's capabilities in cell line development and strengthens its ability to support biopharmaceutical workflows from early development through manufacturing. Together, these technologies enable a more integrated approach to cell line development—linking cell selection, single-cell isolation, and high-confidence clone verification. This is an important step in building a more connected and differentiated platform for cell line development and bioprocessing." The company's portfolio supports critical workflows across cell line development, process development, and manufacturing, enabling customers to improve productivity, quality, and operational efficiency. Its platforms are used in applications including cell line development, single-cell analysis, and cell therapy research.